Figure 1.

Individual disease trajectories. These timelines show the individual course of treatment and trajectories of disease in patients undergoing resection of oligoprogressive lesions after systemic treatment of mRCC. mRCC, metastasized renal cell carcinoma; Nx, nephrectomy; PM, pulmonary metastasectomy; CR, complete remission; PR, partial remission; SD, stable disease; PD, progressive disease; OPD, oligoprogressive disease; OMD, oligometastatic disease; Rx, resection; RT, radiotherapy; LN, lymph node; SIRT, selective internal radiation therapy; ADR, adrenal; PLE, pleural; HEP, hepatic; OTH, other; PUL, pulmonal; OSS, osseous; CUT, cutaneous; B, bilateral; L, leftsided; R, rightsided.